LSIL lesion of the cervix uteri, vagina or vulva

PheWeb

N14_FEMALE_GENITAL_LSIL

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule

Sex only females

180574

Check conditions None

180574

Filter registries

Hospital Discharge: ICD-10 N87.0, N89.0, N90.0

Hospital discharge: ICD-9 6221A|0781C

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 N87.0, N89.0, N90.0

Cause of death: ICD-9 6221A|0781C

Cause of death: ICD-8 $!$

3139

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

3139

Check minimum number of events None

3139

Include endpoints None

3139

N14_FEMALE_GENITAL_LSIL

Extra metadata

First used in FinnGen datafreeze DF7

Similar endpoints

↥

List of similar endpoints to LSIL lesion of the cervix uteri, vagina or vulva based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	3032	3032	-
Unadjusted prevalence (%)	0.98	1.75	-
Mean age at first event (years)	38.08	38.08	-

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.02	1.35 [0.78, 2.33]	2.9e-1	53
15 years	0.01	1.08 [0.62, 1.89]	7.8e-1	26
5 years	0.00	2.13 [1.04, 4.34]	3.8e-2	11
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: N14_FEMALE_GENITAL_LSIL – LSIL lesion of the cervix uteri, vagina or vulva
GWS hits:

Survival analyses between endpoints

↥

Plot

before LSIL lesion of the cervix uteri, vagina or vulva
after LSIL lesion of the cervix uteri, vagina or vulva

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after LSIL lesion of the cervix uteri, vagina or vulva

↥